Cancer Drugs Approved Quickly Often Fail To Measure Up Later
(By Richard Harris for NPR) Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show
Read More(By Richard Harris for NPR) Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show
Read More(By Jackie Fortier, Statelmpact, Oklahoma for Kaiser Health News) All eyes will be on Oklahoma this week when the first
Read More(By Juliette Cubanski, Matthew Rae, Katherine Young, and Anthony Damico for Kaiser Family Foundation) Prescription drug costs are a pressing
Read More(By Andrea Park for Becker’s Hospital Review) A new gene therapy developed for the treatment of malignant glioma, a rare
Read More(By Lauren Weber for Kaiser Health News) Missouri retained its lonely title as the only state without a statewide prescription
Read More(Source – www.cms.gov/newsroom) Today, the Trump Administration finalized improvements to Medicare Advantage and Medicare Part D, which provide seniors with
Read More(By Lev Facher for STAT) WASHINGTON — Two top Democratic lawmakers are questioning Speaker Nancy Pelosi’s strategy to couple legislation
Read MoreA group of 800 hospitals created a nonprofit generic drugmaker called Civica Rx, just revealed the first two treatments they
Read More(By Ed Silverman for STAT) In a bid to maintain its dominance in the HIV market, Gilead Sciences (GILD) allegedly
Read More(Source – www.crfb.org/papers) The Medicare Trustees have released their 2019 report, which makes projections for Medicare spending and revenue for
Read More